yahoo
The Denver Broncos' pursuit of linebacker Daiyan Henley appears far from over, even though a deadline-day trade with the Los Angeles Chargers collapsed due to a discrepancy in his medical evaluation. According to The Athletic's Jonathan Jones, the Chargers will now focus on mending any potential rift with their homegrown talent, while the Broncos continue their Super Bowl aspirations without the promising young linebacker.
Both organizations reportedly believe they will be able to sign Henley five months from now, and Henley himself seemed to confirm Denver's long-term interest in comments made to The Athletic. His future with the Chargers was already in question before the failed trade; The Athletic's Daniel Popper ranked him as the 22nd overall trade candidate and the second among off-ball linebackers.
Henley, a third-round pick in 2023, has shown flashes of potential but has yet to put together a complete elite season, Popper noted in October. In 2025, Henley battled a severe illness early in the season, and this year he was uneven to start before finding better form in Week 3. The Chargers might view him as a long-term building block, but he is in the final year of his rookie deal and has yet to agree to an extension. Los Angeles also has some depth at linebacker.
At his best, Henley can be a difference-maker in coverage, as a blitzer, and as a sideline-to-sideline tackler. That last trait explains why the Broncos' continued interest makes sense. However, Popper's note about health being a noteworthy hurdle for the fourth-year veteran is telling following Denver's polarizing decision. Henley has missed three games in his career and has tallied over 300 total tackles, yet the Broncos had significant concerns about his longevity—enough so that they reneged on a deal they clearly wanted to make.
Key Analysis
The Broncos' efforts to alter the trade terms after the deadline had technically passed and then back out have drawn strong opinions. Multiple general managers told The Sweeps' Tom Pelissero that the league and the competition committee should reexamine teams' ability to renegotiate trade terms once the deadline passes, arguing a team could abuse the system. To be clear: the Broncos were within their rights to go back to the Chargers after receiving the medical reports on Henley, and there is no reason to believe they acted in bad faith.
Other than a single appearance on the injury report in Week 6, Henley's knee wasn't a known issue outside of Los Angeles. When the Broncos' doctors raised concerns about his long-term durability—and additional outside medical opinions backed them up—Denver still tried to find a path forward. The team was willing to send its 2027 fourth-round pick to the Chargers but wanted to adjust and/or place conditions on the 2028 fifth-round pick from the original deal. Pelissero later noted, "The value adjusts based on longevity." But there are 32 teams with 32 doctors and 32 degrees of risk tolerance. The Chargers' doctors see a player they know who has never missed a game because of injury in four NFL seasons; the Broncos' doctors see scans that suggest that may change.
The potential compensatory pick Denver would receive if Henley were to depart in March also could be affected if other teams concur with the Broncos' medical assessment and he signs a lower-money offer. In addition to the fallout for Henley, Pelissero noted that some executives fear teams will abuse the gray area. Chargers head coach Jim Harbaugh insisted it was a loophole the league should look into.
Originally reported by yahoo.